[Clinical experience with bleomycin--a new cytostatic agent for cancer]

The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years.

Cancer·2000

Systemic pneumococcal disease after staging splenectomy for Hodgkin's disease 1969-1980 without pneumococcal vaccine protection: a follow-up study 1994.

European journal of haematology·1997

[Tumor size and histological grading of stage 1 breast cancer. Prognostic and therapeutic significance].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·1996

[Infrastructure for clinical research in a hospital].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·1994

Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1994

Host markers and prognosis in recurrent rectal carcinomas treated with radiotherapy.

Acta oncologica (Stockholm, Sweden)·1994

Perspectives on the use of coercion in highly specialised rehabilitation: a focus group study.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026

Occupational injuries treated at Oslo A&E - a prospective study.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026

Cross-reactivity in cashew nut allergy.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026

The Mechanisms of Ramulus Cinnamomi and Rhizoma Paridis in Gynecological Cancers: A Narrative Review.

Cancer management and research·2026

Environmental endocrine disruptors activate CBX2 to disrupt cholesterol homeostasis in PCOS.

The Journal of steroid biochemistry and molecular biology·2026

Phytochemical characterization of methanolic extract of Cuminum cyminum seeds and its anticancer efficacy against human oral cancer.

Tissue & cell·2026

Schisandrin B protects against oxaliplatin-induced liver injury by suppressing ferroptosis via the canonical KEAP1-Nrf2 and non-canonical microbiota-driven Lactobacillus reuteri-CLA-Nrf2 axes.

Pharmacological research·2026

Clostridium Butyricum and butyrate enhance PD-1 inhibitor therapy in non-small cell lung cancer by regulating the HDAC1/ID2/IL-12R pathway.

Translational oncology·2026

A synergistic cascade nanoreactor breaks bladder cancer chemoresistance: Synergizing cholesterol metabolism reprogramming with cGAS-STING-mediated metallotherapy.

Materials today. Bio·2026

Related Experiment Videos

[Clinical experience with bleomycin--a new cytostatic agent for cancer]

Related Concept Videos

The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years.

Systemic pneumococcal disease after staging splenectomy for Hodgkin's disease 1969-1980 without pneumococcal vaccine protection: a follow-up study 1994.

[Tumor size and histological grading of stage 1 breast cancer. Prognostic and therapeutic significance].

[Infrastructure for clinical research in a hospital].

Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy.

Host markers and prognosis in recurrent rectal carcinomas treated with radiotherapy.

Perspectives on the use of coercion in highly specialised rehabilitation: a focus group study.

Occupational injuries treated at Oslo A&E - a prospective study.

Cross-reactivity in cashew nut allergy.

The Mechanisms of Ramulus Cinnamomi and Rhizoma Paridis in Gynecological Cancers: A Narrative Review.

Environmental endocrine disruptors activate CBX2 to disrupt cholesterol homeostasis in PCOS.

Phytochemical characterization of methanolic extract of Cuminum cyminum seeds and its anticancer efficacy against human oral cancer.

Schisandrin B protects against oxaliplatin-induced liver injury by suppressing ferroptosis via the canonical KEAP1-Nrf2 and non-canonical microbiota-driven Lactobacillus reuteri-CLA-Nrf2 axes.

Clostridium Butyricum and butyrate enhance PD-1 inhibitor therapy in non-small cell lung cancer by regulating the HDAC1/ID2/IL-12R pathway.

A synergistic cascade nanoreactor breaks bladder cancer chemoresistance: Synergizing cholesterol metabolism reprogramming with cGAS-STING-mediated metallotherapy.

Related Experiment Videos

[Clinical experience with bleomycin--a new cytostatic agent for cancer]

Related Concept Videos

Related Articles